Subscribe Us

header ads

Recents

header ads

Healthcare Software As A Service Market Size At Around US$ 79.56 Bn In 2030

The healthcare software as a service market would grow at a CAGR of 11.79% over the predicted time frame. The market is expected to increase in value from US$ 32.62 Bn in 2022 to US$ 79.56 Bn in 2030.

Healthcare Software As A Service Market Size 2022 To 2030

The on healthcare software as a service Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2070

Report Scope of the Healthcare Software As A Service Market

Report CoverageDetails
Market Size in 2022

USD 32.62 Billion

Market Size by 2030

USD 79.56 Billion

Growth Rate from 2022 to 2030CAGR of 11.79%
Base Year2021
Forecast Period2022 to 2030
Segments Covered Product, Delivery Mode, Applications, Deployment, End User and Geography

A recent report provides crucial insights along with application based and forecast information in the Global Healthcare software as a service Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Healthcare software as a service market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Healthcare software as a service market are included as given below:

Healthcare software as a service Market Key Players

  • Jag Products LLC (US)
  • Oracle (U.S)
  • Cognizant (U.S)
  • INFOR  (U.S)
  • Epic Systems Corporation (U.S)
  • Elinext (U.S)
  • Meta (U.S)
  • CPSI (U.S)
  • SAP (Germany)
  • Medical Informatin Techology Inc. (U.S)
  • eClinicalWorks (U.S)
  • athenahealth (U.S)
  • Koninklijke Philip N.V (Netherlands)
  • Change Healthcare (U.S)
  • Cerner Corporation (U.S)
  • Optum Inc. (U.S)
  • Allscripts Healthcare LLC  (U.S)

Market Segments

By Product

  • Ententerprise Content Management
  • Business Intelligence
  • Customer Relationship Management (CRM)
  • Revenue Cycle Management (RCM)

By Delivery Mode

  • Cloud- based
  • On-Premise

By Applications

  • Healthcare Providers
  • Healthcare Players
  • Telemedicine
  • Medical Billing
  • Patient Portal
  • Mobile communication
  • e Prescribing
  • EHR Systems
  • ERP & HR portal
  • Others

By Deployment

  • Public
  • Hybrid
  • Private

By End User

  • Provider
  • Payer

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)

Report Objectives

  • To define, describe, and forecast the global healthcare software as a service market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the healthcare software as a service market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Software As A Service Market 

5.1. COVID-19 Landscape: Healthcare Software As A Service Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Software As A Service Market, By Product

8.1. Healthcare Software As A Service Market, by Product, 2022-2030

8.1.1. Ententerprise Content Management

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Business Intelligence

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Customer Relationship Management (CRM)

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Revenue Cycle Management (RCM)

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare Software As A Service Market, By Delivery Mode

9.1. Healthcare Software As A Service Market, by Delivery Mode, 2022-2030

9.1.1. Cloud- based

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. On-Premise

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Healthcare Software As A Service Market, By Applications 

10.1. Healthcare Software As A Service Market, by Applications, 2022-2030

10.1.1. Health care providers

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Health care players

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Telemedicine

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Medical Billing

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Patient portal

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.5. Mobile communication

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.5. e Prescribing

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.5. EHR Systems

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.5. ERP & HR portal

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Healthcare Software As A Service Market, By Deployment

11.1. Healthcare Software As A Service Market, by Deployment, 2022-2030

11.1.1. Public

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Hybrid

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Private

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Healthcare Software As A Service Market, By End User

12.1. Healthcare Software As A Service Market, by End User, 2022-2030

12.1.1. Provider

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Payer

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Healthcare Software As A Service Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.3. Market Revenue and Forecast, by Applications (2017-2030)

13.1.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Applications (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Applications (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.3. Market Revenue and Forecast, by Applications (2017-2030)

13.2.4. Market Revenue and Forecast, by Deployment (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Applications (2017-2030)

13.2.7. Market Revenue and Forecast, by Deployment (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Applications (2017-2030)

13.2.10. Market Revenue and Forecast, by Deployment (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Applications (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Applications (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.3. Market Revenue and Forecast, by Applications (2017-2030)

13.3.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Applications (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Applications (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Applications (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Applications (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.3. Market Revenue and Forecast, by Applications (2017-2030)

13.4.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Applications (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Applications (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Applications (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Applications (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.3. Market Revenue and Forecast, by Applications (2017-2030)

13.5.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Applications (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Applications (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Deployment (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Jag Products LLC (US)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Oracle (U.S)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Cognizant (U.S)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. INFOR  (U.S)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Epic Systems Corporation (U.S)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Elinext (U.S)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Meta (U.S)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. CPSI (U.S)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. SAP (Germany)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Medical Informatin Techology Inc. (U.S)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments